SWINE Safety profile of the newly registered swine influenza vaccine Respiporc® FLUpan H1N1
Stefan Pesch, Vicky Fachinger
Respiporc Flu range
Respiporc Flu 3 and Respiporc Flu Pan H1N1, the registered range of Influenza vaccines, which delivers the broadest protection against Swine Influenza A Virus (swIAV).
Available in :
- 25 Doses
- 50 Doses
Product information
Active immunisation of pigs from the age of 56 days onwards including pregnant sows against swine influenza caused by subtypes H1N1, H3N2 and H1N2 to reduce clinical signs and viral lung load after infection.
Onset of immunity: 7 days after primary vaccination.
Duration of immunity: 4 months in pigs vaccinated between the age of 56 and 96 days and 6 months in pigs vaccinated for the first time at 96 days and above.
Active immunisation of pregnant sows after finished primary immunisation by administration of a single dose 14 days prior to farrowing to develop high colostral immunity which provides clinical protection of piglets for at least 33 days after birth.
Why choose Respiporc Flu range?
No worries, broadest protection by bundled power
Positive return on investment by improved reproduction parameters
Unique diagnostic support
The Science behind
Efficacy of Respiporc® FLUpan H1N1 under field conditions
Stefan Pesch, Vicky Fachinger
Development of a monovalent pig vaccine based on a human pandemic H1N1 (2009) strain
Stefan Pesch , Vicky Fachinger
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.
